跳至主要内容
临床试验/NCT05089695
NCT05089695招募中不适用

Helmet Noninvasive Ventilation vs. Continuous Positive Airway Pressure vs. High-flow Nasal Oxygen as First-line Treatment of Acute Hypoxemic Respiratory Failure (HENIVOT2). An Open-label, Multicentre Randomized Trial

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,200
试验地点
1
主要终点
Rate of Endotracheal intubation

研究概览

简要总结

Multicenter, open label, three-arm randomized trial to assess the effect of helmet noninvasive ventilation vs. helmet continuous positive airway pressure vs. high-flow nasal oxygen on the rate of endotracheal intubation of patients with acute moderate-to-severe hypoxemic respiratory failure

详细描述

The optimal initial management of acute hypoxemic respiratory failure is uncertain. Helmet noninvasive ventilation and high-flow nasal oxygen appear as the most promising techniques in this setting. Recently, the first head-to-head randomized trial compared first-line continuous treatment with helmet pressure support ventilation with specific settings (PEEP=12 cmH2O pressure and pressure support=10-12 cmH2O) vs. high-flow nasal oxygen alone in patients with moderate-to-severe hypoxemic respiratory failure. Results showed no significant inter-group difference in the days free of respiratory support at 28 days, but lower intubation rate and increased 28-day invasive ventilation-free days in the helmet group. Use of helmet noninvasive ventilation is less frequent than use of helmet continuous positive airway pressure, which is simpler to use.

The investigators designed an open-label, multicentre randomized trial to assess the effect of helmet pressure support ventilation and continuous airway pressure as compared to high-flow nasal oxygen on the intubation rate of patients with moderate-to-severe hypoxemic respiratory failure in the intensive care unit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute symptoms of respiratory failure PaO2/FiO2 ratio ≤ 200; PaCO2≤45mmHg; Absence of history of chronic respiratory failure or moderate to severe cardiac insufficiency (NYHA>2 or left ventricular ejection fraction<50%); Informed consent
  • Patients that have already received NIV, CPAP continuously for more than 24 hours before the screening visit will be excluded.

排除标准

  • Pregnancy;
  • Exacerbation of asthma or chronic obstructive pulmonary disease;
  • Hypercapnia (PaCO2>45 mmHg) with or without respiratory acidosis;
  • More than 2 organ failures, including the lung.
  • Documented pneumothorax;
  • Clinical diagnosis of Cardiogenic pulmonary edema;
  • Haemodynamic instability (Systolic blood pressure<90 mmHg or mean arterial pressure<65mmHg) and/or lactic acidosis (lactate>5 mmol/L) and/or clinically diagnosed Shock requiring administration of vasoactive agents (norepinephrine>0.1 mcg/Kg/min);
  • Metabolic Acidosis (pH <7.30 with normal- or hypo-carbia);
  • Chronic kidney failure requiring dialysis before ICU admission;
  • Chronic hypoxemic respiratory failure requiring long-term oxygen therapy;
  • Altered neurological status that requires immediate intubation and/or making the patient uncooperative;
  • Urgent need for endotracheal intubation, according to the decision of the attending physician;
  • Do not intubate order;
  • Decision of withdrawal of life-sustaining therapy;
  • Thoracic or abdominal surgery in the previous 7 days;
  • Any condition that makes the patient very likely to require endotracheal intubation due to a reason different from respiratory failure;
  • Recent head surgery or anatomy that prevent the application of helmet or HFNC to patient's face.

结局指标

主要结局

Rate of Endotracheal intubation

时间窗: 28 days

The proportion of patients requiring endotracheal intubation according to predefined criteria

次要结局

  • Rate of In-intensive care unit mortality(90 days)
  • Days free of invasive mechanical ventilation at day 28(28 days)
  • Days free of invasive mechanical ventilation at day 60(60 days)
  • Days free of invasive mechanical ventilation at day 90(90 days)
  • Incidence of shock(90 days)
  • Incidence of barotrauma(90 days)
  • Rate of In-hospital care unit mortality(90 days)
  • Rate of 90-day mortality(90 days)
  • Incidence of pneumonia(90 days)
  • 90-day ICU free days(90 days)
  • 90-day hospital free days(90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Helmet NIV vs. CPAP vs. High-flow Nasal Oxygen in... | 临床试验